• Valion Bio named Melinda Lackey general counsel, senior vice president of legal affairs.
• Lackey joins from Alaunos Therapeutics, where she served as senior vice president of legal and administration.
• Earlier roles include senior legal counsel at Kuur Therapeutics, associate positions at Winston & Strawn, Howrey, research posts at University of Texas Health Science Center at Houston, UT MD Anderson Cancer Center.
• Move comes as company advances Entolimod toward an FDA Animal Rule pathway for acute radiation syndrome, scales CDMO unit Velocity Bioworks in San Antonio.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Valion Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-003446), on May 04, 2026, and is solely responsible for the information contained therein.